| Year |
Citation |
Score |
| 2024 |
Kachnic LA, Winter K, Suntharalingam M, Ilson D, Konski A, Lloyd S, McAvoy SA, Lad T, Olowokure OG, Samson P, Gore EM, Meyer JE, Videtic GMM, Clump DA, Raben A, ... ... Bruner DW, et al. Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 39066879 DOI: 10.1007/s11136-024-03736-7 |
0.311 |
|
| 2024 |
Xiao C, Peng G, Conneely KN, Zhao H, Felger JC, Wommack EC, Higgins KA, Shin DM, Saba NF, Bruner DW, Miller AH. DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism. Molecular Psychiatry. PMID 38977918 DOI: 10.1038/s41380-024-02652-z |
0.537 |
|
| 2023 |
Lin Y, Peng G, Bruner DW, Miller AH, Saba NF, Higgins KA, Shin DM, Claussen H, Johnston HR, Houser MC, Wommack EC, Xiao C. Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study. Journal of Psychosomatic Research. 175: 111518. PMID 37832274 DOI: 10.1016/j.jpsychores.2023.111518 |
0.574 |
|
| 2023 |
Xiao C, Fedirko V, Claussen H, Richard Johnston H, Peng G, Paul S, Maner-Smith KM, Higgins KA, Shin DM, Saba NF, Wommack EC, Bruner DW, Miller AH. Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study. Brain, Behavior, and Immunity. PMID 37543249 DOI: 10.1016/j.bbi.2023.07.025 |
0.548 |
|
| 2023 |
Amirkhanzadeh Barandouzi Z, Bruner DW, Miller AH, Paul S, Felger JC, Wommack EC, Higgins KA, Shin DM, Saba NF, Xiao C. Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study. Brain, Behavior, & Immunity - Health. 30: 100649. PMID 37396338 DOI: 10.1016/j.bbih.2023.100649 |
0.552 |
|
| 2023 |
Eldridge RC, Qin ZS, Saba N, Houser MC, Hayes DN, Miller AH, Bruner DW, Jones DP, Xiao C. Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes. Cancers. 15. PMID 37370794 DOI: 10.3390/cancers15123184 |
0.511 |
|
| 2023 |
Huang S, Zhan Y, Jeon S, Bruner DW, Miller AH, Felger JC, Wommack EC, Saba NF, Higgins KA, Irwin ML, Gary RA, Xiao C. Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer. Head & Neck. PMID 37288586 DOI: 10.1002/hed.27420 |
0.543 |
|
| 2023 |
Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, ... ... Bruner DW, et al. Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202389. PMID 37104723 DOI: 10.1200/JCO.22.02389 |
0.3 |
|
| 2023 |
Bai J, Pugh SL, Eldridge R, Yeager KA, Zhang Q, Lee WR, Shah AB, Dayes IS, D'Souza DP, Michalski JM, Efstathiou JA, Longo JM, Pisansky TM, Maier JM, Faria SL, ... ... Bruner DW, et al. Neighborhood Deprivation and Rurality Associated with Patient-Reported Outcomes and Survival in Men with Prostate Cancer in NRG RTOG 0415. International Journal of Radiation Oncology, Biology, Physics. PMID 36736921 DOI: 10.1016/j.ijrobp.2023.01.035 |
0.313 |
|
| 2022 |
Qian DC, Ulrich BC, Peng G, Zhao H, Conneely KN, Miller AH, Bruner DW, Eldridge RC, Wommack EC, Higgins KA, Shin DM, Saba NF, Smith AK, Burtness B, Park HS, et al. Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood. International Journal of Radiation Oncology, Biology, Physics. PMID 36410685 DOI: 10.1016/j.ijrobp.2022.11.009 |
0.503 |
|
| 2022 |
Lin Y, Bruner DW, Paul S, Miller AH, Saba NF, Higgins KA, Shin DM, Zhang W, Miaskowski C, Xiao C. A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy. Cancer. PMID 35969226 DOI: 10.1002/cncr.34424 |
0.559 |
|
| 2022 |
Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, Konski AA, Gaffney DK, Small W, Thompson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, ... ... Bruner DW, et al. Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102831. PMID 35960897 DOI: 10.1200/JCO.21.02831 |
0.324 |
|
| 2021 |
Tsementzi D, Meador R, Eng T, Patel P, Shelton J, Arluck J, Scott I, Dolan M, Khanna N, Konstantinidis KT, Bruner DW. Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers. Frontiers in Cellular and Infection Microbiology. 11: 680038. PMID 34778097 DOI: 10.3389/fcimb.2021.680038 |
0.317 |
|
| 2021 |
Eldridge RC, Uppal K, Hayes DN, Smith MR, Hu X, Qin ZS, Beitler JJ, Miller AH, Wommack EC, Higgins KA, Shin DM, Ulrich BC, Qian DC, Saba NF, Bruner DW, et al. Plasma metabolic phenotypes of HPV-associated vs smoking-associated head and neck cancer and patient survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34376485 DOI: 10.1158/1055-9965.EPI-21-0576 |
0.492 |
|
| 2021 |
Xiao C, Beitler JJ, Peng G, Levine ME, Conneely KN, Zhao H, Felger JC, Wommack EC, Chico CE, Jeon S, Higgins KA, Shin DM, Saba NF, Burtness BA, Bruner DW, et al. Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study. Cancer. PMID 34027995 DOI: 10.1002/cncr.33641 |
0.605 |
|
| 2021 |
Xiao C, Miller AH, Peng G, Levine ME, Conneely KN, Zhao H, Eldridge RC, Wommack EC, Jeon S, Higgins KA, Shin DM, Saba NF, Smith AK, Burtness B, Park HS, ... ... Bruner DW, et al. Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33882281 DOI: 10.1016/j.ijrobp.2021.04.002 |
0.549 |
|
| 2020 |
Xiao C, Fedirko V, Beitler J, Bai J, Peng G, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Jeon S, Knobf TM, Conneely KN, Higgins K, Shin DM, ... ... Bruner D, et al. The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 33078326 DOI: 10.1007/s00520-020-05820-3 |
0.525 |
|
| 2020 |
Bai J, Bruner DW, Fedirko V, Beitler JJ, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Higgins KA, Shin DM, Saba NF, Miller AH, Xiao C. Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers. Cancers. 12. PMID 32899975 DOI: 10.3390/Cancers12092531 |
0.601 |
|
| 2020 |
Yeager KA, Waldrop-Valverde D, Paul S, Bruner DW, Klisovic R, Burns E, Mason TA, Patel N, Jennings BM. Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol. Research in Nursing & Health. PMID 32866350 DOI: 10.1002/Nur.22069 |
0.346 |
|
| 2020 |
Yeager KA, Bai J, Gogineni K, Meisel JL, Kweon J, Bruner DW, Waldrop-Valverde D. Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 32654039 DOI: 10.1007/S13187-020-01826-X |
0.372 |
|
| 2020 |
Xiao C, Eldridge RC, Beitler JJ, Higgins KA, Chico CE, Felger JC, Wommack EC, Knobf T, Saba NF, Shin DM, Bruner DW, Miller AH. Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer. Psychosomatic Medicine. 82: 508-516. PMID 32515926 DOI: 10.1097/Psy.0000000000000816 |
0.625 |
|
| 2020 |
Kang Y, Meghani SH, Bruner DW, Yeager KA. Factors Associated with Depression in African American Patients Being Treated for Cancer Pain. Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses. PMID 32513560 DOI: 10.1016/J.Pmn.2020.03.006 |
0.373 |
|
| 2020 |
Xiao C, Beitler JJ, Higgins KA, Chico CE, Withycombe JS, Zhu Y, Zhao H, Lin IH, Li F, Jeon S, Irwin M, Bruner DW, Miller AH, Gary R. Pilot Study of Combined Aerobic and Resistance Exercise on Fatigue for Patients with Head and Neck Cancer: Inflammatory and Epigenetic Changes. Brain, Behavior, and Immunity. PMID 32330594 DOI: 10.1016/J.Bbi.2020.04.044 |
0.547 |
|
| 2020 |
Tsementzi D, Pena-Gonzalez A, Bai J, Hu YJ, Patel P, Shelton J, Dolan M, Arluck J, Khanna N, Conrad L, Scott I, Eng TY, Konstantinidis KT, Bruner DW. Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women. Cancer Medicine. PMID 32237205 DOI: 10.1002/Cam4.3027 |
0.369 |
|
| 2020 |
Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, ... ... Bruner DW, et al. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902381. PMID 32073955 DOI: 10.1200/Jco.19.02381 |
0.42 |
|
| 2020 |
Dueck AC, Becker CC, Rogak LJ, Schrag D, Reeve B, Spears P, Smith ML, Gounder MM, Mahoney MR, Schwartz GK, Bennett AV, Mendoza TR, Cleeland CS, Sloan JA, Bruner D, et al. Composite grading algorithm for National Cancer Institute’s PRO-CTCAE. Journal of Clinical Oncology. 38: 7018-7018. DOI: 10.1200/Jco.2020.38.15_Suppl.7018 |
0.304 |
|
| 2019 |
Xiao C, Bruner DW, Dai T, Guo Y, Hanlon A. A Comparison of Missing-Data Imputation Techniques in Exploratory Factor Analysis. Journal of Nursing Measurement. 27: 313-334. PMID 31511412 DOI: 10.1891/1061-3749.27.2.313 |
0.481 |
|
| 2019 |
Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom S, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C. Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. Head & Neck. PMID 31435980 DOI: 10.1002/Hed.25922 |
0.61 |
|
| 2019 |
Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, ... ... Bruner DW, et al. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecologic Oncology. PMID 31104905 DOI: 10.1016/J.Ygyno.2019.04.682 |
0.406 |
|
| 2019 |
Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, et al. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 135: 19-24. PMID 31015166 DOI: 10.1016/J.Radonc.2019.02.014 |
0.377 |
|
| 2019 |
Chung AE, Shoenbill K, Mitchell SA, Dueck AC, Schrag D, Bruner DW, Minasian LM, St Germain D, O'Mara AM, Baumgartner P, Rogak LJ, Abernethy AP, Griffin AC, Basch EM. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Journal of the American Medical Informatics Association : Jamia. 26: 276-285. PMID 30840079 DOI: 10.1093/Jamia/Ocy169 |
0.416 |
|
| 2019 |
Bruner DW, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, et al. Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 30763425 DOI: 10.1001/Jamaoncol.2018.6752 |
0.39 |
|
| 2019 |
Gondi V, Deshmukh S, Brown PD, Wefel JS, Tome W, Armstrong T, Bruner D, Bovi JA, Robinson CG, Khuntia D, Grosshans DR, Konski AA, Roberge D, Kundapur V, Devisetty K, et al. NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM). Journal of Clinical Oncology. 37: 2009-2009. DOI: 10.1200/Jco.2019.37.15_Suppl.2009 |
0.341 |
|
| 2019 |
Eldridge RC, Flanders WD, Adler C, Bruner DW, Xiao C. Abstract 2418: Are we underestimating cancer mortality? A mediation model shows a larger impact from smoking Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-2418 |
0.533 |
|
| 2019 |
Pollack A, Karrison T, Balogh AG, Low D, Bruner DW, Wefel JS, Gomella* LG, Martin A, Michalski JM, Angyalfi SJ, Lukka H, Faria SL, Rodrigues GB, Beauchemin M, Lee RJ, et al. MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557133.04919.Da |
0.306 |
|
| 2019 |
Wefel JS, Pugh S, Gondi V, Brown PD, Tome W, Armstrong TS, Bruner D, Bovi J, Robinson C, Khuntia D, Grosshans D, Konski A, Roberge D, Kundapur V, Devisetty K, et al. NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM) Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_642 |
0.323 |
|
| 2019 |
Armstrong T, Deshmukh S, Brown P, Gondi V, Benzinger T, Gilbert M, Tome W, Wefel J, Bruner D, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Baschnagel A, et al. ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001 Neuro-Oncology. 21: vi24-vi25. DOI: 10.1093/Neuonc/Noz175.092 |
0.346 |
|
| 2019 |
Xiao C, Beitler J, Higgins K, Zhu Y, Zhao H, Bruner D, Miller A, Gary R. Abstract #4314 Pilot study of combined aerobic resistance exercise on fatigue and inflammation for patients with head and neck cancer Brain, Behavior, and Immunity. 81: 29. DOI: 10.1016/J.Bbi.2019.08.099 |
0.586 |
|
| 2018 |
Xiao C, Beitler JJ, Higgins KA, Wommack EC, Saba NF, Shin DM, Bruner DW, Miller AH, Cole S. Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain, Behavior, and Immunity. PMID 30217537 DOI: 10.1016/J.Bbi.2018.09.013 |
0.573 |
|
| 2018 |
Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, Wind JK, Shaw MC, Heon N, Shi Q, Ginos B, Nelson GD, Meyers JP, Chang GJ, Mamon HJ, ... ... Bruner DW, et al. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018788620. PMID 30204536 DOI: 10.1200/Jco.2018.78.8620 |
0.419 |
|
| 2018 |
Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, ... ... Bruner DW, et al. Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. Advances in Radiation Oncology. 3: 405-411. PMID 30202809 DOI: 10.1016/J.Adro.2018.04.010 |
0.591 |
|
| 2018 |
Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, ... ... Bruner DW, et al. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017774273. PMID 29989857 DOI: 10.1200/Jco.2017.77.4273 |
0.408 |
|
| 2018 |
Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, et al. Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29913254 DOI: 10.1016/J.Ijrobp.2018.06.008 |
0.404 |
|
| 2018 |
Bai J, Brubaker A, Meghani SH, Bruner DW, Yeager KA. Spirituality and Quality of Life in Black Patients with Cancer Pain. Journal of Pain and Symptom Management. PMID 29857179 DOI: 10.1016/J.Jpainsymman.2018.05.020 |
0.355 |
|
| 2018 |
Xiao C, Beitler JJ, Higgins KA, Glazer T, Huynh LK, Paul S, Felger JC, Wommack EC, Saba NF, Shin DM, Bruner DW, Miller AH. Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. Cancer. PMID 29742284 DOI: 10.1002/Cncr.31537 |
0.55 |
|
| 2018 |
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, et al. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. Jama Oncology. PMID 29543933 DOI: 10.1001/Jamaoncol.2018.0039 |
0.415 |
|
| 2018 |
Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis A, Laba J, ... ... Bruner DW, et al. Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. Journal of Clinical Oncology. 36: 2065-2065. DOI: 10.1200/Jco.2018.36.15_Suppl.2065 |
0.32 |
|
| 2018 |
Eldridge RC, Miller AH, Bruner DW, Beitler JJ, Higgins KA, Wommack EC, Huynh LK, Saba NF, Shin DM, Xiao C. Abstract 4257: Predicting fatigue levels of head and neck cancer patients with gene expression using machine learning Epidemiology. DOI: 10.1158/1538-7445.Am2018-4257 |
0.57 |
|
| 2018 |
Gondi V, Pugh S, D Brown P, Wefel J, Gilbert M, Bovi J, Robinson C, Tammie B, Tome W, Armstrong T, Bruner D, Khuntia D, Grosshans D, Konski A, Robidoux A, et al. NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001 Neuro-Oncology. 20: vi172-vi172. DOI: 10.1093/Neuonc/Noy148.716 |
0.306 |
|
| 2018 |
Ferris M, Switchenko J, Xiao C, McDonald M, Eaton B, Higgins K, Press R, Tian S, Steuer C, Baddour H, Miller A, Bruner D, Beitler J. Medulla Dose is Positively Associated with Sensation of Thirst & Midbrain Dose is Inversely Associated with Pain: Prospectively-Collected Patient-Reported Toxicities and Brainstem Dose in Head and Neck Cancer Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e198. DOI: 10.1016/J.Ijrobp.2018.07.708 |
0.579 |
|
| 2017 |
Bai J, Behera M, Bruner DW. The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29168036 DOI: 10.1007/S00520-017-3982-3 |
0.319 |
|
| 2017 |
Ferris MJ, Zhong J, Switchenko JM, Higgins KA, Cassidy RJ, McDonald MW, Eaton BR, Patel KR, Steuer CE, Baddour HM, Miller AH, Bruner DW, Xiao C, Beitler JJ. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28826628 DOI: 10.1016/J.Radonc.2017.08.008 |
0.624 |
|
| 2017 |
Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, Rogak LJ, Gatewood M, Reeve BB, Mendoza TR, O'Mara AM, Denicoff AM, Minasian LM, Bennett AV, Setser A, ... ... Bruner DW, et al. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. International Journal of Radiation Oncology, Biology, Physics. 98: 409-418. PMID 28463161 DOI: 10.1016/J.Ijrobp.2017.02.002 |
0.355 |
|
| 2017 |
Hanlon A, Small W, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, Wells J, Bruner DW. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study. Cancer Nursing. PMID 28437283 DOI: 10.1097/Ncc.0000000000000500 |
0.363 |
|
| 2017 |
Fogh SE, Deshmukh S, Berk LB, Dueck AC, Roof K, Yacoub S, Gergel T, Stephans K, Rimner A, DeNittis A, Pablo J, Rineer J, Williams TM, Bruner D. A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. International Journal of Radiation Oncology, Biology, Physics. 97: 786-796. PMID 28244415 DOI: 10.1016/J.Ijrobp.2016.11.022 |
0.425 |
|
| 2017 |
Xiao C, Beitler J, Higgins K, Glazer T, Huynh L, Paul S, Wommack E, Saba N, Shin D, Bruner D, Miller A. HPV status is associated with fatigue and inflammation in patients with squamous cell carcinoma of the Head and Neck from pre to up to 3 Months Post IMRT Brain, Behavior, and Immunity. 66: e36. DOI: 10.1016/J.Bbi.2017.07.132 |
0.591 |
|
| 2016 |
Yeager K, Meghani S, Cooper H, Quest T, Williams B, Kweon J, Haight S, Bruner D. (385) Opiate adherence in African Americans being treated for cancer pain. The Journal of Pain : Official Journal of the American Pain Society. 17: S71. PMID 28162630 DOI: 10.1016/J.Jpain.2016.01.362 |
0.329 |
|
| 2016 |
Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom SS, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, ... Bruner DW, et al. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire - RTOG Modification. Journal of Pain and Symptom Management. PMID 27899312 DOI: 10.1016/J.Jpainsymman.2016.11.002 |
0.369 |
|
| 2016 |
Wagner LI, Pugh SL, Small W, Kirshner J, Sidhu K, Bury MJ, DeNittis AS, Alpert TE, Tran B, Bloom BF, Mai J, Yeh A, Sarma K, Becker M, James J, ... Bruner DW, et al. Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Cancer. PMID 27861753 DOI: 10.1002/Cncr.29969 |
0.336 |
|
| 2016 |
Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, ... ... Bruner D, et al. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. International Journal of Radiation Oncology, Biology, Physics. PMID 27727066 DOI: 10.1016/J.Ijrobp.2016.08.003 |
0.422 |
|
| 2016 |
Xiao C, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, ... ... Bruner D, et al. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. International Journal of Radiation Oncology, Biology, Physics. PMID 27727063 DOI: 10.1016/J.Ijrobp.2016.07.020 |
0.604 |
|
| 2016 |
Ferris MJ, Zhong J, Switchenko J, Higgins KA, McDonald MW, Eaton BR, Miller AH, Bruner DW, Xiao C, Beitler JJ. CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E357. PMID 27674471 DOI: 10.1016/J.Ijrobp.2016.06.1529 |
0.589 |
|
| 2016 |
Wells JS, Pugh S, Boparai K, Rearden J, Yeager KA, Bruner DW. Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials-an NRG Oncology RTOG Study. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 27209044 DOI: 10.1007/S13187-016-1051-0 |
0.341 |
|
| 2016 |
Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria SL, et al. Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27044935 DOI: 10.1200/Jco.2016.67.0448 |
0.395 |
|
| 2016 |
Lukka H, Pugh SL, Bruner D, Bahary J, Lawton CA, Efstathiou JA, Kudchadker R, Ponsky LE, Seaward SA, Dayes IS, Gopaul D, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, et al. Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP). Journal of Clinical Oncology. 34: 27-27. DOI: 10.1200/Jco.2016.34.2_Suppl.27 |
0.339 |
|
| 2016 |
Lee WR, Dignam JJ, Amin M, Bruner D, Low D, Swanson GP, Shah A, D'Souza D, Michalski JM, Dayes I, Seaward SA, Hall WA, Nguyen PL, Pisansky TM, Faria S, et al. NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer. Journal of Clinical Oncology. 34: 1-1. DOI: 10.1200/Jco.2016.34.2_Suppl.1 |
0.334 |
|
| 2016 |
Lee W, Dignam J, Amin M, Bruner D, Low D, Swanson G, Shah A, D'Souza D, Michalski J, Dayes I, Seaward S, Hall W, Nguyen P, Pisansky T, Faria S, et al. NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 94: 3-4. DOI: 10.1016/J.Ijrobp.2015.10.049 |
0.382 |
|
| 2016 |
Lukka H, Stephanie P, Bruner D, Bahary J, Lawton C, Efstathiou J, Kudchadker R, Ponsky L, Seaward S, Dayes I, Gopaul D, Michalski J, Delouya G, Kaplan I, Horwitz E, et al. Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 94: 2. DOI: 10.1016/J.Ijrobp.2015.10.046 |
0.343 |
|
| 2015 |
Xiao C, Beitler JJ, Higgins KA, Conneely K, Dwivedi B, Felger J, Wommack EC, Shin DM, Saba NF, Ong LY, Kowalski J, Bruner DW, Miller AH. Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy. Brain, Behavior, and Immunity. PMID 26515035 DOI: 10.1016/J.Bbi.2015.10.016 |
0.607 |
|
| 2015 |
Mao JJ, Bowman MA, Xie SX, Bruner D, DeMichele A, Farrar JT. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26304905 DOI: 10.1200/Jco.2015.60.9412 |
0.358 |
|
| 2015 |
Bruner DW, Pugh SL, Yeager KA, Bruner J, Curran W. Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials. International Journal of Radiation Oncology, Biology, Physics. 93: 702-9. PMID 26281827 DOI: 10.1016/J.Ijrobp.2015.06.041 |
0.323 |
|
| 2015 |
Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD, Gillis TA, ... ... Bruner DW, et al. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Jama Oncology. PMID 26270597 DOI: 10.1001/Jamaoncol.2015.2639 |
0.373 |
|
| 2015 |
Meghani SH, Thompson AM, Chittams J, Bruner DW, Riegel B. Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device. The Journal of Pain : Official Journal of the American Pain Society. PMID 26080042 DOI: 10.1016/J.Jpain.2015.05.009 |
0.325 |
|
| 2015 |
Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin M, Xiao C, Bahary JP, Patel M, Chafe S, Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, et al. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. Cancer. 121: 2422-30. PMID 25847819 DOI: 10.1002/Cncr.29362 |
0.574 |
|
| 2015 |
Mao JJ, Xie SX, Bowman MA, Bruner D, Li SQ, DeMichele A, Farrar JT. Abstract PD4-7: A randomized placebo-controlled trial of acupuncture and gabapentin for hot flashes among breast cancer survivors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd4-7 |
0.372 |
|
| 2015 |
Konski A, Buyyounouski M, Stoyanova R, Movsas B, Uzzo R, Horwitz E, Kwon D, Bruner D, Pollack A. Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S118-S119. DOI: 10.1016/J.Ijrobp.2015.07.283 |
0.385 |
|
| 2015 |
Xiao C, Beitler J, Higgins K, Felger J, Conneely K, Dwivedi B, Kowalski J, Bruner D, Miller A. Gene expression changes and fatigue during IMRT in patients with head and neck cancer Brain, Behavior, and Immunity. 49: e28-e29. DOI: 10.1016/J.Bbi.2015.06.115 |
0.558 |
|
| 2014 |
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute. 106. PMID 25265940 DOI: 10.1093/Jnci/Dju244 |
0.402 |
|
| 2014 |
Pisansky TM, Bruner DW, Greenberg RE. Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer--reply. Jama. 312: 748-9. PMID 25138339 DOI: 10.1001/Jama.2014.7923 |
0.358 |
|
| 2014 |
Yang X, Tridandapani S, Beitler JJ, Yu DS, Chen Z, Kim S, Bruner DW, Curran WJ, Liu T. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy. Academic Radiology. 21: 1304-13. PMID 25088832 DOI: 10.1016/J.Acra.2014.05.017 |
0.344 |
|
| 2014 |
Mao JJ, Farrar JT, Bruner D, Zee J, Bowman M, Seluzicki C, DeMichele A, Xie SX. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial. Cancer. 120: 3744-51. PMID 25077452 DOI: 10.1002/Cncr.28917 |
0.366 |
|
| 2014 |
Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of the National Cancer Institute. 106. PMID 25006191 DOI: 10.1093/Jnci/Dju129 |
0.409 |
|
| 2014 |
Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. Journal of the National Cancer Institute. 106. PMID 25006190 DOI: 10.1093/Jnci/Dju128 |
0.325 |
|
| 2014 |
Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. Journal of the National Cancer Institute. 106. PMID 25006189 DOI: 10.1093/Jnci/Dju127 |
0.386 |
|
| 2014 |
Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. Jama. 311: 1300-7. PMID 24691606 DOI: 10.1001/Jama.2014.2626 |
0.4 |
|
| 2014 |
Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 23: 1841-58. PMID 24492945 DOI: 10.1007/S11136-014-0628-5 |
0.433 |
|
| 2014 |
Xiao C, Bruner DW, Jennings BM, Hanlon AL. Methods for examining cancer symptom clusters over time. Research in Nursing & Health. 37: 65-74. PMID 24414939 DOI: 10.1002/Nur.21572 |
0.531 |
|
| 2014 |
Mao JJ, Tan T, Li SQ, Meghani SH, Glanz K, Bruner D. Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study. Bmc Complementary and Alternative Medicine. 14: 7. PMID 24400734 DOI: 10.1186/1472-6882-14-7 |
0.377 |
|
| 2014 |
Xiao C, Hanlon A, Zhang Q, Movsas B, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Le Q, Bruner DW. Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129. Cancer. 120: 848-54. PMID 24338990 DOI: 10.1002/Cncr.28500 |
0.575 |
|
| 2014 |
Mao JJ, Xie SX, Farrar JT, Stricker CT, Bowman MA, Bruner D, DeMichele A. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use. European Journal of Cancer (Oxford, England : 1990). 50: 267-76. PMID 24210070 DOI: 10.1016/J.Ejca.2013.09.022 |
0.35 |
|
| 2014 |
Yeager KA, Bruner J, Pugh SL, Bruner DW. Abstract A71: Clinical trial participation: Differences in distance traveled across different ethnic groups Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-A71 |
0.341 |
|
| 2014 |
Xiao C, Beitler J, Higgins K, Felger J, Ong L, Shin D, Saba N, Bruner D, Miller A. Increased Fatigue Is Associated With TNF and NFκB-Regulated Inflammatory Signaling in Patients With Head and Neck Cancer Receiving IMRT International Journal of Radiation Oncology*Biology*Physics. 90: S571. DOI: 10.1016/J.Ijrobp.2014.05.1723 |
0.609 |
|
| 2014 |
Xiao C, Beitler J, Higgins K, Felger J, Bruner J, Flynn T, Bruner D, Andrew A. 128. The relationship between inflammation and fatigue development in patients with head and neck cancer receiving IMRT Brain, Behavior, and Immunity. 40: e37. DOI: 10.1016/J.Bbi.2014.06.148 |
0.588 |
|
| 2013 |
Bruner DW, O'Mara A. Nurse scientists in cancer cooperative groups. Seminars in Oncology Nursing. 30: 4-10. PMID 24559774 DOI: 10.1016/J.Soncn.2013.12.002 |
0.353 |
|
| 2013 |
Meghani SH, Bruner DW. A pilot study to identify correlates of intentional versus unintentional nonadherence to analgesic treatment for cancer pain. Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses. 14: e22-30. PMID 23688368 DOI: 10.1016/J.Pmn.2011.03.003 |
0.306 |
|
| 2013 |
Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. International Journal of Radiation Oncology, Biology, Physics. 86: 656-64. PMID 23597420 DOI: 10.1016/J.Ijrobp.2013.02.033 |
0.36 |
|
| 2013 |
Flynn KE, Reeve BB, Lin L, Cyranowski JM, Bruner DW, Weinfurt KP. Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer. Health and Quality of Life Outcomes. 11: 40. PMID 23497200 DOI: 10.1186/1477-7525-11-40 |
0.32 |
|
| 2013 |
Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, Weinfurt KP. Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. The Journal of Sexual Medicine. 10: 43-52. PMID 23387911 DOI: 10.1111/J.1743-6109.2012.02995.X |
0.306 |
|
| 2013 |
Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1525-50. PMID 23314601 DOI: 10.1007/S00520-012-1688-0 |
0.399 |
|
| 2013 |
Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Movsas B, Bruner DW. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncology. 49: 360-6. PMID 23168337 DOI: 10.1016/J.Oraloncology.2012.10.004 |
0.598 |
|
| 2013 |
Xiao C, Polomano R, Bruner DW. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nursing. 36: E1-E16. PMID 23047799 DOI: 10.1097/Ncc.0B013E318269040F |
0.592 |
|
| 2013 |
Mao JJ, Xie S, Farrar JT, Stricker CT, Bowman M, Bruner D, DeMichele A. Electro-acupuncture for joint pain related to aromatase inhibitors among breast cancer survivors: A randomized placebo-controlled trial. Journal of Clinical Oncology. 31: 9639-9639. DOI: 10.1200/Jco.2013.31.15_Suppl.9639 |
0.332 |
|
| 2013 |
Wagner LI, Pugh SL, Small W, Kirshner JJ, Sidhu K, Bury MJ, DeNittis AS, Alpert TE, Tran BN, Bloom B, Mai J, Bruner D. Screening for depression in community-based radiation oncology settings: Results from RTOG 0841. Journal of Clinical Oncology. 31: 9527-9527. DOI: 10.1200/Jco.2013.31.15_Suppl.9527 |
0.323 |
|
| 2013 |
Bruner D, Pugh SL, Pisansky TM, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA. Preliminary results of RTOG 0831, a randomized, double-blinded, placebo-controlled trial of tadalafil in the prevention of erectile dysfunction in patients treated with radiotherapy for prostate cancer. Journal of Clinical Oncology. 31: 9525-9525. DOI: 10.1200/Jco.2013.31.15_Suppl.9525 |
0.363 |
|
| 2013 |
Yang X, Beitler J, Yu D, Tridandapani S, Bruner D, Curran W, Liu T. Quantitative Ultrasound Evaluation of Post-Radiation Therapy Sialadenitis and Fibrosis of the Parotid Glands in Patients Following Head-and-Neck Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S459. DOI: 10.1016/J.Ijrobp.2013.06.1212 |
0.327 |
|
| 2013 |
Small W, Pugh S, Wagner L, Kirshner J, Sidhu K, Bury M, DeNittis A, Alpert T, Tran B, Bruner D. RTOG 0841: Two-Item Questionnaire Effectively Screens for Depression in Cancer Patients Receiving Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S2. DOI: 10.1016/J.Ijrobp.2013.06.013 |
0.372 |
|
| 2012 |
Bauml J, Xie SX, Penn C, Desai K, Dong KW, Bruner DW, Vapiwala N, Mao JJ. A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy. Journal of Palliative Care & Medicine. 2. PMID 29479490 DOI: 10.4172/2165-7386.1000125 |
0.452 |
|
| 2012 |
Bekelman JE, Deye JA, Vikram B, Bentzen SM, Bruner D, Curran WJ, Dignam J, Efstathiou JA, FitzGerald TJ, Hurkmans C, Ibbott GS, Lee JJ, Merchant TE, Michalski J, Palta JR, et al. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. International Journal of Radiation Oncology, Biology, Physics. 83: 782-90. PMID 22425219 DOI: 10.1016/J.Ijrobp.2011.12.080 |
0.382 |
|
| 2012 |
Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE. Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 83: e13-9. PMID 22381899 DOI: 10.1016/J.Ijrobp.2011.11.072 |
0.394 |
|
| 2012 |
Hanisch LJ, Bryan CJ, James JL, Pisansky TM, Corbett TB, Parliament MB, Stewart CE, Hartford AC, Sandler H, Berk LB, Kachnic L, Bruner DW. Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer: Analysis of RTOG 0215 Supportive Care in Cancer. 20: 2845-2850. PMID 22354624 DOI: 10.1007/S00520-012-1409-8 |
0.406 |
|
| 2012 |
Du KL, Bae K, Movsas B, Yan Y, Bryan C, Bruner DW. Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 1317-25. PMID 21720747 DOI: 10.1007/S00520-011-1219-4 |
0.44 |
|
| 2012 |
Bahng AY, Dagan A, Bruner DW, Lin LL. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. International Journal of Radiation Oncology, Biology, Physics. 82: 667-73. PMID 21300451 DOI: 10.1016/J.Ijrobp.2010.10.071 |
0.398 |
|
| 2011 |
Chow E, James JL, Hartsell W, Scarantino CW, Ivker R, Roach M, Iii, Suh JH, Demas W, Konski A, Bruner DW. Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714. World Journal of Oncology. 2: 181-190. PMID 29147245 DOI: 10.4021/Wjon325W |
0.375 |
|
| 2011 |
Lee WR, Dignam J, Bruner D, Efstathiou JA, Yan Y, Hanks GE, Roach M, Pilepich MV, Sandler HM. Does enrollment setting influence patient attributes and outcomes in RTOG prostate cancer trials? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4607. PMID 28024019 DOI: 10.1200/Jco.2011.29.15_Suppl.4607 |
0.37 |
|
| 2011 |
Gondi V, Paulus R, Bruner D, Meyers CA, Gore E, Wolfson AH, Werner-Wasik M, Choy H, Movsas B. Prognostic significance of QOL deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 6061. PMID 28021828 DOI: 10.1200/Jco.2011.29.15_Suppl.6061 |
0.356 |
|
| 2011 |
Bruner DW, Hanisch LJ, Reeve BB, Trotti AM, Schrag D, Sit L, Mendoza TR, Minasian L, O'Mara A, Denicoff AM, Rowland JH, Montello M, Geoghegan C, Abernethy AP, Clauser SB, et al. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Translational Behavioral Medicine. 1: 110-22. PMID 24073038 DOI: 10.1007/S13142-011-0025-3 |
0.422 |
|
| 2011 |
Basch EM, Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner D. Electronic toxicity monitoring and patient-reported outcomes. Cancer Journal (Sudbury, Mass.). 17: 231-4. PMID 21799330 DOI: 10.1097/Ppo.0B013E31822C28B3 |
0.374 |
|
| 2011 |
Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Leibenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, Shipley WU. Radiotherapy and short-term androgen deprivation for localized prostate cancer. The New England Journal of Medicine. 365: 107-18. PMID 21751904 DOI: 10.1056/Nejmoa1012348 |
0.36 |
|
| 2011 |
Bae K, Bruner DW, Baek S, Movsas B, Corn BW, Dignam JJ. Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials. Journal of Neuro-Oncology. 105: 383-95. PMID 21603964 DOI: 10.1007/S11060-011-0603-8 |
0.376 |
|
| 2011 |
Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, Howell D, Konski A, Kachnic L, Lo S, Sahgal A, Silverman L, von Gunten C, Mendel E, Vassil A, ... Bruner DW, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. International Journal of Radiation Oncology, Biology, Physics. 79: 965-76. PMID 21277118 DOI: 10.1016/J.Ijrobp.2010.11.026 |
0.323 |
|
| 2011 |
Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal D, Nguyen-Tan P, Kim H, Movsas B, Bruner D. Predictors on Longitudinal Changes of Clinician Reported Symptom Clusters Identified in Patients with Head and Neck Cancer Treated on RTOG Trials International Journal of Radiation Oncology*Biology*Physics. 81: S534. DOI: 10.1016/J.Ijrobp.2011.06.830 |
0.626 |
|
| 2011 |
Gondi V, Paulus R, Bruner D, Meyers C, Gore E, Wolfson A, Werner-Wasik M, Choy H, Movsas B. Decline in Tested and Patient-reported Cognitive Functioning Following Prophylactic Cranial Irradiation for Lung Cancer: Secondary Analysis of RTOG 0212 and 0214 International Journal of Radiation Oncology*Biology*Physics. 81: S50. DOI: 10.1016/J.Ijrobp.2011.06.100 |
0.34 |
|
| 2010 |
Ulrich CM, James JL, Walker EM, Stine SH, Gore E, Prestidge B, Michalski J, Gwede CK, Chamberlain R, Bruner DW. RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. Contemporary Clinical Trials. 31: 221-8. PMID 20215046 DOI: 10.1016/J.Cct.2010.03.002 |
0.322 |
|
| 2010 |
Chow E, James J, Barsevick A, Hartsell W, Ratcliffe S, Scarantino C, Ivker R, Roach M, Suh J, Petersen I, Konski A, Demas W, Bruner D. Functional Interference Clusters in Cancer Patients With Bone Metastases: A Secondary Analysis of RTOG 9714 International Journal of Radiation Oncology Biology Physics. 76: 1507-1511. PMID 19632065 DOI: 10.1016/J.Ijrobp.2009.04.024 |
0.321 |
|
| 2010 |
Friedman CF, Bruner D, Xie S, Desai K, Stricker CT, DeMichele A, Mao J. Functional disability and aromatase inhibitor-associated arthralgia in breast cancer survivors. Journal of Clinical Oncology. 28: 9156-9156. DOI: 10.1200/Jco.2010.28.15_Suppl.9156 |
0.35 |
|
| 2009 |
Desai K, DeMichele A, Bruner D, Vapiwala N, Hughes Halbert C, Stricker C, Mao JJ. Factors associated with willingness to participate in an acupuncture clinical trial for arthralgia among breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6596. PMID 27963895 DOI: 10.1200/Jco.2009.27.15_Suppl.6596 |
0.414 |
|
| 2009 |
Meghani SH, Lee CS, Hanlon AL, Bruner DW. Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities. Bmc Medical Informatics and Decision Making. 9: 47. PMID 19941668 DOI: 10.1186/1472-6947-9-47 |
0.356 |
|
| 2009 |
Mao JJ, Bruner DW, Stricker C, Farrar JT, Xie SX, Bowman MA, Pucci D, Han X, DeMichele A. Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors. Integrative Cancer Therapies. 8: 123-9. PMID 19679620 DOI: 10.1177/1534735409332903 |
0.344 |
|
| 2009 |
Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 115: 3631-9. PMID 19517460 DOI: 10.1002/Cncr.24419 |
0.329 |
|
| 2009 |
Mao J, Stricker C, Farrar J, Xie S, Bowman M, Bruner D, Pucci D, Han X, DeMichele A. Feasibility trial of electro-acupuncture for aromatase inhibitor related arthralgia in breast cancer survivors. Cancer Research. 69: 3105. DOI: 10.1158/0008-5472.Sabcs-3105 |
0.383 |
|
| 2009 |
Mao J, Stricker C, Bruner D, Farrar J, Bowman M, Xie S, Wolf J, DeMichele A. Onset and risk factors for aromatase inhibitor-related arthralgia in breast cancer survivors. Cancer Research. 69: 1120. DOI: 10.1158/0008-5472.Sabcs-1120 |
0.394 |
|
| 2009 |
Mao J, Gehrman P, Su I, Bruner D, Xie S, Sehamy AE, DeMichele A. Prevalence and Risk Factors for Insomnia in Breast Cancer Survivors Receiving Aromatase Inhibitors. Cancer Research. 69: 1062-1062. DOI: 10.1158/0008-5472.Sabcs-09-1062 |
0.375 |
|
| 2008 |
Bryan CJ, Wetmore-Arkader L, Calvano T, Deatrick JA, Giri VN, Bruner DW. Using focus groups to adapt ethnically appropriate, information-seeking and recruitment messages for a prostate cancer screening program for men at high risk. Journal of the National Medical Association. 100: 674-82. PMID 18595569 DOI: 10.1016/S0027-9684(15)31340-7 |
0.319 |
|
| 2008 |
Hartsell WF, Desilvio M, Bruner DW, Scarantino C, Ivker R, Roach M, Suh J, Demas WF, Movsas B, Petersen IA, Konski AA. Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. Journal of Palliative Medicine. 11: 723-8. PMID 18588404 DOI: 10.1089/Jpm.2007.0259 |
0.38 |
|
| 2008 |
Bruner DW, Calvano T. The sexual impact of cancer and cancer treatments in men. The Nursing Clinics of North America. 42: 555-80; vi. PMID 17996755 DOI: 10.1016/J.Cnur.2007.07.005 |
0.327 |
|
| 2007 |
Bruner DW. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5345-7. PMID 18048812 DOI: 10.1200/Jco.2007.13.3330 |
0.396 |
|
| 2007 |
Lipscomb J, Reeve BB, Clauser SB, Abrams JS, Bruner DW, Burke LB, Denicoff AM, Ganz PA, Gondek K, Minasian LM, O'Mara AM, Revicki DA, Rock EP, Rowland JH, Sgambati M, et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5133-40. PMID 17991933 DOI: 10.1200/Jco.2007.12.4644 |
0.409 |
|
| 2007 |
Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5051-7. PMID 17991920 DOI: 10.1200/Jco.2007.11.3324 |
0.397 |
|
| 2007 |
Bruner DW. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model. Journal of the National Cancer Institute. Monographs. 12-5. PMID 17951225 DOI: 10.1093/Jncimonographs/Lgm004 |
0.365 |
|
| 2007 |
Bruner DW, Barsevick A, Tian C, Randall M, Mannel R, Cohn DE, Sorosky J, Spirtos NM. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 16: 89-100. PMID 17033909 DOI: 10.1007/S11136-006-9003-5 |
0.385 |
|
| 2007 |
Nicolaou N, Moughan J, Sarna L, Langer C, Werner-Wasik M, Komaki R, Machtay M, Wasserman T, Bruner D, Movsas B. Quality of Life (QOL) Supercedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC): An Analysis of Radiation Therapy Oncology Group (RTOG) 9801 International Journal of Radiation Oncology*Biology*Physics. 69: S58-S59. DOI: 10.1016/J.Ijrobp.2007.07.107 |
0.345 |
|
| 2006 |
Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2209-15. PMID 16682741 DOI: 10.1200/Jco.2005.04.8116 |
0.406 |
|
| 2005 |
Hartsell WF, Winter K, Bruner DW, Scarantino CW, Ivker R, Roach M, Suh JH, Demas W, Movsas B, Petersen I, Konski A. Breast cancer patients have better outcomes than prostate cancer patients for palliation of painful bone metastases: Results of RTOG 97-14. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6073. PMID 27945927 DOI: 10.1200/Jco.2005.23.16_Suppl.6073 |
0.368 |
|
| 2001 |
Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, DeSilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, et al. Genitourinary cancer committee International Journal of Radiation Oncology Biology Physics. 51: 28-38. DOI: 10.1016/S0360-3016(01)01777-1 |
0.391 |
|
| Show low-probability matches. |